Medtronic, Bayer HealthCare expand global alliance to develop next generation diabetes management solutions

Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.

“With Medtronic's industry-leading insulin pump technology and our advanced blood glucose meter and strip technology, we believe we can provide people with diabetes a convenient solution for better glucose control”

Since 2007, the two companies have successfully collaborated internationally in over 20 countries by providing Bayer's CONTOUR^® Link meter to people with diabetes who use compatible MiniMed Paradigm^® insulin pumps and the Guardian^® REAL-Time continuous glucose monitoring (CGM) system from Medtronic.

"Our goal is to improve patient outcomes while delivering an exceptional customer experience," said Katie Szyman, president of the Diabetes business and senior vice president at Medtronic. "We are excited to work with Bayer to develop and deliver future integrated solutions that are even smaller and easier to use, with accuracy that surpasses today's standards in diabetes management."

"With Medtronic's industry-leading insulin pump technology and our advanced blood glucose meter and strip technology, we believe we can provide people with diabetes a convenient solution for better glucose control," said Alan Main, president of Bayer Medical Care. "With a strong history of innovation similar to Bayer's, Medtronic is an ideal collaborator with whom we can share complementary technologies, resources and talent to support patients and simplify their diabetes care."